PubMed Health⌕ Search

Biomedical subjects

Ira M Longini

Publications and source records attributed to Ira M Longini.

21 records · Page 2Linked to original sources

Epidemic and endemic cholera trends over a 33-year period in Bangladesh.

Despite nearly 200 years of study, the mechanisms contributing to the maintenance of endemic cholera and the causes of periodic epidemics remain poorly understood. To investigate these patterns, cholera data collected over 33 years (1966-1998) in Matlab, Bangladesh, were analyzed. Time-lagged autocorrelations were stratified by Vibrio cholerae serogroup, serotype, and biotype. Both classical and El Tor biotypes alternated and persisted between 1966 and 1988; the classical biotype disappeared by 1988, and the O139 serogroup first appeared in 1993. Both the Ogawa and Inaba serotypes circulated the entire time. The autocorrelations revealed that both Inaba and Ogawa epidemics were followed 12 months later by epidemics of the same serotype. Ogawa epidemics, however, were also followed by further Ogawa epidemics only 6 months later. Thus, epidemics of Inaba may selectively confer short-term population-level immunity for a longer period than those of Ogawa. These observations suggest that the Inaba antigen should be maximized in cholera vaccine designs.

Bangladesh↗

Model-based estimation of vaccine effects from community vaccine trials.

Community vaccine trials are becoming increasingly important to assess both the direct and indirect community level effects of vaccination. In this paper, we present statistical methods to analyse such trials, using a design with several matched pairs of communities. The communities are matched on similarities in infection transmission as reflected through the basic reproduction number. Two methods of analysis are presented and compared. The first is simple empirical estimation of vaccine effects. Summary measures of these effects are constructed by reciprocal variance weighted averages across the community pairs. The second is likelihood-based where we derive a mixed effects epidemic model. This model takes the intercommunity variability into account through a random effect on the basic reproduction number. With this model, we derive a distribution-free estimator for the variance of the random effect. We use simulated epidemics to explore the performance of the two estimation methods for different numbers of community pairs and different levels of inter-pair variability. Both methods provide acceptable estimates in terms of bias and precision under reasonable conditions. Although the empirical approach involves fewer assumptions than the model-based approach, the resulting vaccine effectiveness estimates are only applicable to the vaccination fraction tested in the trial. In contrast, the model-based approach can be used to predict the vaccine effectiveness at vaccination fractions other than those used in the trial. Thus, it can be used as a public health policy tool for predicting the community level effects of vaccination. We demonstrate such use by predicting total vaccine effectiveness for the whole range of vaccination fractions.

Computer Simulation↗

Subtype-specific transmission probabilities for human immunodeficiency virus type 1 among injecting drug users in Bangkok, Thailand.

The Bangkok (Thailand) Metropolitan Administration cohort of injecting drug users (IDUs) consisted of 1,209 IDUs initially seronegative for human immunodeficiency virus (HIV) who were followed from 1995 to 1998 at 15 Administration drug treatment clinics. At enrollment and approximately every 4 months thereafter, participants were assessed for HIV seropositivity. As of December 1998, there were 133 HIV type 1 seroconversions and approximately 2,300 person-years of follow-up. Of the 133 observed seroconversions, specimens from 126 persons were available for subtyping (27 subtype B, 99 subtype E). In this analysis, the authors assessed differences in subtype-specific transmission while controlling for important risk factors. The methodology used accounts for left truncation, interval censoring, and competing risks as well as for time-varying covariates such as each IDU's history of reported frequency of injection and of incarceration. Using plausible epidemiologic assumptions and controlling for behavioral risks, the authors found that a significantly higher transmission probability was associated with subtype E compared with subtype B in this population. Since many epidemiologic, virologic, and host factors can influence HIV transmission, it was difficult to conclude whether these differences in transmission probabilities were due to biologic properties associated with subtype.

Adolescent↗